Avion

Executive Summary

Avion Medical is an Australian full-service Contract Research Organisation (CRO) founded in 2020, specializing in oncology, dermatology, and radiopharmaceutical trials. The company differentiates itself through proprietary platforms—MOOSE AI for automated image segmentation, Avi.Data cloud for real-time data management, and Avi.Suite for integrated trial workflows—delivering end-to-end services from protocol design to regulatory submission. With 200-500 employees and a commercial-stage status, Avion has rapidly positioned itself as a niche player in radiopharmaceutical development, a high-growth area with increasing demand for precision imaging and dosimetry services. Its AI-driven approach enhances trial efficiency, reducing timelines and costs for sponsors while maintaining robust data integrity.

Upcoming Catalysts (preview)

• Q3 2026Major radiopharmaceutical trial award from top-10 pharma40% success
• Q4 2026Regulatory clearance for MOOSE AI in dosimetry for NMPA or FDA30% success
• Q2 2026Partnership with a global imaging CRO for AI segmentation expansion50% success